https://www.selleckchem.com/pr....oducts/Dihydroartemi
OBJECTIVE To compare the diagnostic accuracy of dilatation and curettage (DC) versus endometrial aspiration biopsy in follow-up evaluation of patients treated with progestin for endometrial hyperplasia (EH). METHODS A prospective multicenter study was conducted from 2015 to 2018. Patients with EH were treated with progestin, one of the following three treatment regimens oral medroxyprogesterone acetate (MPA) 10 mg/day for 14 days per cycle, continuous MPA 10 mg/day or the levonorgestrel-releasing intrauterine system
Like
Comment
Share
